Target intelligence / Profile preview

Calcium voltage-gated channel auxiliary subunit gamma 5 (CACNG5)

Target
CACNG5
Molecular classification
Ion channel auxiliary subunit, Transmembrane AMPA receptor regulatory protein (TARP), Calcium channel auxiliary subunit
01

Overview

Calcium voltage-gated channel auxiliary subunit gamma 5 (CACNG5) is a type II transmembrane protein that belongs to the family of gamma subunits of voltage-dependent calcium channels and is also classified as a transmembrane AMPA receptor regulatory protein (TARP)[1][5][8]. CACNG5 regulates AMPA-type glutamate receptors (AMPARs) by accelerating their rates of activation, deactivation, and desensitization, and it shows specificity for certain AMPAR subunits such as GRIA1, GRIA4, and the long isoform of GRIA2[5][1][8]. It stabilizes voltage-gated calcium channels in an inactivated state, thus modulating neuronal excitability[8][1]. CACNG5 is involved in neurotransmitter receptor internalization and trafficking and is genetically associated with increased risk of psychiatric disorders, including bipolar disorder and schizophrenia[1][6]. There are currently no clinically approved drugs that specifically target CACNG5.

Other names
Voltage-dependent calcium channel gamma-5 subunitCalcium channel, voltage-dependent, gamma subunit 5Neuronal voltage-gated calcium channel gamma-5 subunitTransmembrane AMPAR regulatory protein gamma-5TARP gamma-5
02

Mechanism of action

Modulation of AMPA receptor trafficking and gating; Modulation of voltage-dependent calcium channel properties

03

Biological functions

Regulation of AMPA-type glutamate receptor channel gating (modulation of activation, deactivation, desensitization)Regulation of AMPA receptor trafficking to the synaptic membraneStabilization of voltage-gated calcium channels in an inactivated (closed) stateNeurotransmitter receptor internalization
04

Disease associations

Bipolar disorderSchizophreniaDyskeratosis congenita, autosomal recessive 2
05

Safety considerations

Potential central nervous system effects due to modulation of glutamatergic neurotransmissionPotential psychiatric and neurodevelopmental safety concerns, given genetic associations with psychiatric disorders

Beyond the preview

Go deeper on Calcium voltage-gated channel auxiliary subunit gamma 5 (CACNG5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calcium voltage-gated channel auxiliary subunit gamma 5 (CACNG5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call